StockData
Precision BioSciences Inc logo

Precision BioSciences Inc (DTIL) stock

DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3068% above fair value
$7.40+0.49 (+7.09%)

Close on Nov 20, 2026Market cap $204.25MP/E –Yield –

Precision BioSciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Precision BioSciences's free cash flow for the twelve months ending Jun 30, 2026 was -$51.94M. For fiscal 2025 it was -$65.93M. The highest annual figure on record is -$15.91M in fiscal 2021.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$65.93M–
FY2024Dec 31, 2024-$58.70M–
FY2023Dec 31, 2023-$86.07M–
FY2022Dec 31, 2022-$49.07M–
FY2021Dec 31, 2021-$15.91M–
FY2020Dec 31, 2020-$92.42M–
FY2019Dec 31, 2019-$95.68M–
FY2018Dec 31, 2018-$66.00M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$13.44M–
Q1 FY2026Mar 31, 2026-$11.96M–
Q4 FY2025Dec 31, 2025-$11.27M–
Q3 FY2025Sep 30, 2025-$15.27M–
Q2 FY2025Jun 30, 2025-$20.27M–
Q1 FY2025Mar 31, 2025-$19.12M–
Q4 FY2024Dec 31, 2024-$18.78M–
Q3 FY2024Sep 30, 2024-$5.95M–
Q2 FY2024Jun 30, 2024-$14.90M–
Q1 FY2024Mar 31, 2024-$19.07M–
Q4 FY2023Dec 31, 2023-$8.40M–
Q3 FY2023Sep 30, 2023-$23.48M-183.6%
Q2 FY2023Jun 30, 2023-$22.21M–
Q1 FY2023Mar 31, 2023-$31.99M–
Q4 FY2022Dec 31, 2022-$22.48M–
Q3 FY2022Sep 30, 2022$28.10M–
Q2 FY2022Jun 30, 2022-$25.00M–
Q1 FY2022Mar 31, 2022-$29.69M-144.3%
Q4 FY2021Dec 31, 2021-$25.19M–
Q3 FY2021Sep 30, 2021-$24.64M–
Q2 FY2021Jun 30, 2021-$33.03M–
Q1 FY2021Mar 31, 2021$66.95M–
Q4 FY2020Dec 31, 2020-$14.55M–
Q3 FY2020Sep 30, 2020-$23.27M–
Q2 FY2020Jun 30, 2020-$27.59M–
Q1 FY2020Mar 31, 2020-$27.01M–
Q4 FY2019Dec 31, 2019-$26.09M–
Q3 FY2019Sep 30, 2019-$19.90M–
Q2 FY2019Jun 30, 2019-$24.71M–
Q1 FY2019Mar 31, 2019-$24.99M–
Q4 FY2018Dec 31, 2018-$22.78M–
Q3 FY2018Sep 30, 2018-$17.71M–
Q2 FY2018Jun 30, 2018-$10.44M–
Q1 FY2018Mar 31, 2018-$15.07M–

More Precision BioSciences figures

See a number that looks wrong?